Correlation Between Sana Biotechnology and Hard To

Can any of the company-specific risk be diversified away by investing in both Sana Biotechnology and Hard To at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sana Biotechnology and Hard To into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sana Biotechnology and Hard to Treat, you can compare the effects of market volatilities on Sana Biotechnology and Hard To and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sana Biotechnology with a short position of Hard To. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sana Biotechnology and Hard To.

Diversification Opportunities for Sana Biotechnology and Hard To

0.0

Correlation Coefficient

Sana Biotechnology  Hard To

Pay attention - limited upside

The 3 months correlation between Sana and Hard is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sana Biotechnology and Hard to Treat in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hard to Treat and Sana Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sana Biotechnology are associated (or correlated) with Hard To. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hard to Treat has no effect on the direction of Sana Biotechnology i.e., Sana Biotechnology and Hard To go up and down completely randomly.

Pair Corralation between Sana Biotechnology and Hard To

If you would invest  248.00  in Sana Biotechnology on October 11, 2024 and sell it today you would earn a total of  182.00  from holding Sana Biotechnology or generate 73.39% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sana Biotechnology  vs.  Hard to Treat

Sana Biotechnology

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Sana Biotechnology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sana Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Hard to Treat

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hard to Treat has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Hard To is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Sana Biotechnology and Hard To

The main advantage of trading using opposite Sana Biotechnology and Hard To positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sana Biotechnology position performs unexpectedly, Hard To can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hard To will offset losses from the drop in Hard To's long position.

The idea behind Sana Biotechnology and Hard to Treat pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.